Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 53

1.

The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A.

Jousselin A, Manzano C, Biette A, Reed P, Pinho MG, Rosato AE, Kelley WL, Renzoni A.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1656-66. doi: 10.1128/AAC.02333-15.

PMID:
26711778
2.

Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus.

Andrey DO, Jousselin A, Villanueva M, Renzoni A, Monod A, Barras C, Rodriguez N, Kelley WL.

PLoS One. 2015 Aug 14;10(8):e0135579. doi: 10.1371/journal.pone.0135579. eCollection 2015.

3.

Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.

Kelley WL, Jousselin A, Barras C, Lelong E, Renzoni A.

Antimicrob Agents Chemother. 2015 Apr;59(4):1922-30. doi: 10.1128/AAC.04068-14. Epub 2015 Jan 12.

4.

Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing.

Bæk KT, Frees D, Renzoni A, Barras C, Rodriguez N, Manzano C, Kelley WL.

PLoS One. 2013 Sep 30;8(9):e77122. doi: 10.1371/journal.pone.0077122. eCollection 2013.

5.

The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance.

Jousselin A, Kelley WL, Barras C, Lew DP, Renzoni A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3283-92. doi: 10.1128/AAC.00220-13. Epub 2013 Apr 29.

6.

Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights into a complex genetic puzzle.

Kelley WL, Lew DP, Renzoni A.

J Infect Dis. 2012 Oct;206(8):1153-6. Epub 2012 Aug 16. No abstract available.

7.

The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus.

Jousselin A, Renzoni A, Andrey DO, Monod A, Lew DP, Kelley WL.

Antimicrob Agents Chemother. 2012 Jul;56(7):3629-40. doi: 10.1128/AAC.06264-11. Epub 2012 Apr 23.

8.

Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus.

Reyes D, Andrey DO, Monod A, Kelley WL, Zhang G, Cheung AL.

J Bacteriol. 2011 Nov;193(21):6020-31. doi: 10.1128/JB.05436-11. Epub 2011 Sep 9.

9.

Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus.

Renzoni A, Andrey DO, Jousselin A, Barras C, Monod A, Vaudaux P, Lew D, Kelley WL.

PLoS One. 2011;6(6):e21577. doi: 10.1371/journal.pone.0021577. Epub 2011 Jun 27.

10.

Return of the Trojan horse: intracellular phenotype switching and immune evasion by Staphylococcus aureus.

Garzoni C, Kelley WL.

EMBO Mol Med. 2011 Mar;3(3):115-7. doi: 10.1002/emmm.201100123. Epub 2011 Feb 25. Review. No abstract available.

11.

Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Didier JP, Villet R, Huggler E, Lew DP, Hooper DC, Kelley WL, Vaudaux P.

Antimicrob Agents Chemother. 2011 May;55(5):1946-52. doi: 10.1128/AAC.01407-10. Epub 2011 Feb 28.

12.

Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance.

Galbusera E, Renzoni A, Andrey DO, Monod A, Barras C, Tortora P, Polissi A, Kelley WL.

Antimicrob Agents Chemother. 2011 Mar;55(3):1008-20. doi: 10.1128/AAC.00720-10. Epub 2010 Dec 20.

13.

Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA.

Andrey DO, Renzoni A, Monod A, Lew DP, Cheung AL, Kelley WL.

J Bacteriol. 2010 Nov;192(22):6077-85. doi: 10.1128/JB.00146-10. Epub 2010 Sep 24.

14.

Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus.

Renzoni A, Kelley WL, Vaudaux P, Cheung AL, Lew DP.

Trends Microbiol. 2010 Feb;18(2):55-6. doi: 10.1016/j.tim.2009.11.005. Epub 2009 Dec 11. Review. No abstract available.

15.

Increased uptake and improved intracellular survival of a teicoplanin-resistant mutant of methicillin-resistant Staphylococcus aureus in non-professional phagocytes.

Renzoni A, Huggler E, Kelley WL, Lew D, Vaudaux P.

Chemotherapy. 2009;55(3):183-8. doi: 10.1159/000215304. Epub 2009 Apr 30.

PMID:
19407446
16.

Transcriptomic and metabolic responses of Staphylococcus aureus exposed to supra-physiological temperatures.

Fleury B, Kelley WL, Lew D, Götz F, Proctor RA, Vaudaux P.

BMC Microbiol. 2009 Apr 22;9:76. doi: 10.1186/1471-2180-9-76.

17.

Staphylococcus aureus: new evidence for intracellular persistence.

Garzoni C, Kelley WL.

Trends Microbiol. 2009 Feb;17(2):59-65. doi: 10.1016/j.tim.2008.11.005. Epub 2009 Feb 7. Review.

PMID:
19208480
18.

Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.

Renzoni A, Kelley WL, Barras C, Monod A, Huggler E, François P, Schrenzel J, Studer R, Vaudaux P, Lew DP.

Antimicrob Agents Chemother. 2009 Mar;53(3):903-11. doi: 10.1128/AAC.01287-08. Epub 2008 Dec 22.

19.

The Hsp70 chaperone machines of Escherichia coli: a paradigm for the repartition of chaperone functions.

Genevaux P, Georgopoulos C, Kelley WL.

Mol Microbiol. 2007 Nov;66(4):840-57. Epub 2007 Oct 4. Review.

20.

A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells.

Garzoni C, Francois P, Huyghe A, Couzinet S, Tapparel C, Charbonnier Y, Renzoni A, Lucchini S, Lew DP, Vaudaux P, Kelley WL, Schrenzel J.

BMC Genomics. 2007 Jun 14;8:171.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk